144 related articles for article (PubMed ID: 34966342)
1. A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma.
Yuan F; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Cong Z; Ma C
Front Neurol; 2021; 12():704130. PubMed ID: 34966342
[TBL] [Abstract][Full Text] [Related]
2. Identification and Functional Enrichment Analysis of Potential Diagnostic and Therapeutic Targets in Adamantinomatous Craniopharyngioma.
Zou YF; Meng LB; Wang QQ; He ZK; Hu CH; Shan MJ; Wang DY; Yu X
J Comput Biol; 2020 Jan; 27(1):55-68. PubMed ID: 31424286
[TBL] [Abstract][Full Text] [Related]
3. Integrative analyses identify HIF-1α as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma.
Gao Q; Luo J; Pan J; Zhang L; Song D; Zhang M; Xu D; Guo F
Front Immunol; 2022; 13():949509. PubMed ID: 36091021
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Cancer Gene Ther; 2018 Oct; 25(9-10):227-239. PubMed ID: 29681617
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma.
Lin D; Zhao W; Yang J; Wang H; Zhang H
Front Genet; 2022; 13():830793. PubMed ID: 35432485
[TBL] [Abstract][Full Text] [Related]
6. Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
Zhou Q; Yan X; Liu W; Yin W; Xu H; Cheng D; Jiang X; Ren C
Front Oncol; 2020; 10():586019. PubMed ID: 33425739
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
8. Analysis of KLRB1-mediated immunosuppressive regulation in adamantinomatous craniopharyngioma.
Wei W
J Neurol Surg A Cent Eur Neurosurg; 2024 Apr; ():. PubMed ID: 38657676
[TBL] [Abstract][Full Text] [Related]
9. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP
Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of m
Yuan F; Cai X; Wang Y; Du C; Cong Z; Zeng X; Tang C; Ma C
Int Immunopharmacol; 2023 Nov; 124(Pt A):110784. PubMed ID: 37607464
[TBL] [Abstract][Full Text] [Related]
11. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
Kitsou M; Ayiomamitis GD; Zaravinos A
Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
[TBL] [Abstract][Full Text] [Related]
12. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of primary human cell cultures as a model for adamantinomatous craniopharyngioma research: Evidence from RNA-Seq analysis.
Zhang PD; Wang CH; Fan J; Peng JX; Pan J; Qi ST; Liu Y
Oncol Lett; 2020 Mar; 19(3):2346-2354. PubMed ID: 32194734
[TBL] [Abstract][Full Text] [Related]
14. Proteomics study of primary and recurrent adamantinomatous craniopharyngiomas.
Deng H; Lei T; Liu S; Hao W; Hu M; Xiang X; Ye L; Chen D; Li Y; Liu F
Clin Proteomics; 2024 Apr; 21(1):29. PubMed ID: 38594611
[TBL] [Abstract][Full Text] [Related]
15. Machine learning approach to screen new diagnostic features of adamantinomatous craniopharyngioma and explore personalised treatment strategies.
Wu J; Qin C; Fang G; Shen L; Li M; Lu B; Li Y; Yao X; Fang D
Transl Pediatr; 2023 May; 12(5):947-966. PubMed ID: 37305719
[TBL] [Abstract][Full Text] [Related]
16. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
[TBL] [Abstract][Full Text] [Related]
17. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets.
Prince E; Whelan R; Donson A; Staulcup S; Hengartner A; Vijmasi T; Agwu C; Lillehei KO; Foreman NK; Johnston JM; Massimi L; Anderson RCE; Souweidane MM; Naftel RP; Limbrick DD; Grant G; Niazi TN; Dudley R; Kilburn L; Jackson EM; Jallo GI; Ginn K; Smith A; Chern JJ; Lee A; Drapeau A; Krieger MD; Handler MH; Hankinson TC;
Acta Neuropathol Commun; 2020 May; 8(1):68. PubMed ID: 32404202
[TBL] [Abstract][Full Text] [Related]
19. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract][Full Text] [Related]
20. The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness.
Wang Z; Guo X; Gao L; Deng K; Lian W; Bao X; Feng M; Duan L; Zhu H; Xing B
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3207-23. PubMed ID: 32652004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
